THRIVENT FINANCIAL FOR LUTHERANS - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$136
-76.1%
31,474
-63.6%
0.00%
-100.0%
Q2 2023$570
-5.9%
86,427
-3.2%
0.00%0.0%
Q1 2023$606
-10.0%
89,295
-1.9%
0.00%
-50.0%
Q4 2022$673
-99.9%
91,067
-0.5%
0.00%0.0%
Q3 2022$904,000
+49.4%
91,488
+64.8%
0.00%0.0%
Q2 2022$605,000
+17.9%
55,499
+22.4%
0.00%
+100.0%
Q1 2022$513,000
-27.8%
45,354
+0.0%
0.00%0.0%
Q4 2021$711,000
-7.8%
45,339
+0.8%
0.00%
-50.0%
Q3 2021$771,000
-21.1%
44,973
-1.0%
0.00%0.0%
Q2 2021$977,000
+44.3%
45,422
+0.7%
0.00%
+100.0%
Q1 2021$677,000
+13.8%
45,085
-0.4%
0.00%0.0%
Q4 2020$595,000
+35.5%
45,270
-0.3%
0.00%0.0%
Q3 2020$439,000
-15.4%
45,4020.0%0.00%
-50.0%
Q2 2020$519,000
+12.1%
45,402
+1.6%
0.00%0.0%
Q1 2020$463,000
-33.6%
44,701
+5.3%
0.00%0.0%
Q4 2019$697,000
+24.2%
42,470
+0.4%
0.00%0.0%
Q3 2019$561,000
-3.6%
42,281
+2.4%
0.00%0.0%
Q2 2019$582,000
-21.1%
41,300
+3.0%
0.00%0.0%
Q1 2019$738,000
-23.8%
40,086
+8.1%
0.00%
-33.3%
Q4 2018$969,000
+16.5%
37,074
+2.2%
0.00%0.0%
Q3 2018$832,000
-3.9%
36,259
-61.0%
0.00%
-25.0%
Q4 2015$866,00093,0600.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders